Results

Total Results: 2,034 records

Showing results for "time".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
    May 01, 2008 - measure exposure to antidepressants or attempt to control for patient factors that may change over time … Study Base The person-time eligible for inclusion in this nested case-control study (i.e., the study … base within which the case-control study was nested) was all up-to-standard person-time occurring … In particular, potential controls were persons who contributed person-time to the study base (defined … This is analogous to time-to-event analyses of cohort studies, and ensures the interpretability of the
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
    January 01, 2020 - and 2007–2008 (13 to 34 percent), the prevalence of overweight has remained stable between the same time … more affluent neighborhoods.4 Progression to obesity from normal weight can occur gradually over time … Although the average weight gained per year is 1-2 pounds, the modest accumulation of weight over time … problem-solving, relapse prevention, and stimulus control.25 Other approaches may include regulating time … physical activity are numerous (e.g., consolidation of exercise and everyday activities or making time
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-one-year-disposition-comments.pdf
    June 02, 2023 - • Reviewers made some specific suggestions regarding arm names and outcome time-points that were … reflect that ACOG has worked with the information that was available and the resources available at the time … systematic review: • Interrante 2022 – This article was published after the date of last search at the time … • Wouk 2022 – This article was published after the date of last search at the time of the draft
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
    May 20, 2013 - and small bowel transit time in addition to colonic transit. … However, the value of small bowel transit time in clinical gastroenterology is unclear. … , colonic transit time and whole gut transit. … and therefore colonic transit time is missing in up to 5% of tests. … Peer Reviewer-4 Results KQ 1/2 I think expulsion time rather than expellation time is more commonly
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/bundled-payments-quality-effects_research-protocol.pdf
    June 23, 2011 - between the following different types of aggregation: Aggregation of services longitudinally in time … is defined to encompass services related to a health care treatment or condition within a defined time … In addition, the bundles in some newer payment programs span longer time periods than previously used … anchor‖ of the episodes of care, what other types of services are included in the episode, how the time … results in separate payment for bundled service, such as moving the date of service outside of the time
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
    April 01, 2012 - We excluded studies of participants with known glaucoma at the time of screening (KQs 1, 2, 4, and … The original OCT devices all used time-domain analysis of the collected data. … required to collect lower resolution images using the time-domain devices. … It takes less time to flatten a soft eye (low IOP) than a hard eye (high 6 IOP). … These instruments are all automated and administered by a technician after a short training time.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
    August 18, 2016 - prior and current therapy); and how to efficiently and effectively monitor individuals with ADHD over time … strategy is determined, a monitoring strategy is applied to ensure that outcomes are evaluated over time … Several instruments are available to monitor treatment response and adverse effects over time, including … criteria emphasize the life-long, chronic nature of ADHD and the need to monitor individuals over time … Timing for labeling can be any time after the ADHD diagnosis.
  8. effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
    June 01, 2010 - patients’ prognosis.6,7 In addition, the inclusion of data from observational studies increases the time … and resources required to complete a comparative effectiveness review (CER) which is already a time … is important in cohort studies in which outcomes in comparison groups may be assessed at different time … Such subjects, who tolerated and responded to a particular drug for short time period (e.g., 6 weeks … The best evidence for these outcomes came from a time-series study based on employment records merged
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
    June 01, 2010 - patients’ prognosis.6,7 In addition, the inclusion of data from observational studies increases the time … and resources required to complete a comparative effectiveness review (CER) which is already a time … is important in cohort studies in which outcomes in comparison groups may be assessed at different time … Such subjects, who tolerated and responded to a particular drug for short time period (e.g., 6 weeks … The best evidence for these outcomes came from a time-series study based on employment records merged
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nitric-oxide_research-protocol.pdf
    September 06, 2016 - While the severity of disease varies between patients and over time in the same patient, asthma can … inherent variability in the disease, the non-specific nature of many measures of response, and the time … of testing but outcome ascertained at age 5 or older Interventions FeNO measurement (one-time or … age 5 or older • Patients with recurrent wheezing episodes Interventions FeNO measurement (one-time … Source: www.effectivehealthcare.ahrq.gov Published online: September 6, 2016 9 (personnel time
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
    April 01, 2013 - of nine trials and one controlled observational study found a nonsignificant prolongation of the time … However, these devices significantly increased the time needed to conduct the PCI procedure in three … The only significant finding was increased time to perform a PCI procedure compared with control for … Do Not Know However, these devices significantly increased the time needed to conduct the PCI procedure … The only significant finding was increased time to perform a PCI procedure compared with control for
  12. effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - for treatment of symptomatic neurogenic orthostatic hypotension No high-impact potential at this time … Glybera gene therapy for lipoprotein lipase deficiency No high-impact potential at this time 8. … Off-label bevacizumab for treatment of retinopathy of prematurity No high-impact potential at this time … to onset of symptom relief versus placebo (2.0 hours vs. 19.8 hours) and the median time to onset … Anticipated cost information is unavailable at this time.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/clinical-pathway-methods-report.pdf
    December 01, 2018 - UPHS clinical pathway development process steps and direct time allocation for pathway development … C. difficile treatment pathway views over time ...................................................... … analytics dashboards (Appendix D). 3 Analytics includes pathway views over time. … C. difficile treatment pathway views over time 12 Figure 4a. … Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26(1):13-24.
  14. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - Aspiration system (AspireAssist) for treatment of obesity No high impact potential at this time 2. … Development of obesity was at one time thought to be simply a product of caloric intake that exceeded … research expert stating that “initial results from trials are virtually always more rosy than the long-termeffects.” … Will Arena's Belviq be the next anti-obesity drug to make the cover of Time Magazine?
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
    December 01, 2012 - Over time, adenomas can become cancerous. … (KQs 1 and 2) and time to recurrence (KQs 3 and 4). … For survival and other time-to-event outcomes, it is essential for authors to report the time point … from which the event was measured (e.g., time from liver-directed therapy, time from CRC diagnosis, … time from diagnosis of metastases)
  16. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Edited to provide specific time frames for KQ 1. … We did not define time frames of interest for QoL and other patient-centered outcomes. … As the child usually outgrows his/her need for the tubes, often by the time of tube extrusion, the … The time course of these QOL, behavioral, and language outcomes is not specified. … The time horizons for QoL vary by key question and by study.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Edited to provide specific time frames for KQ 1. … We did not define time frames of interest for QoL and other patient-centered outcomes. … As the child usually outgrows his/her need for the tubes, often by the time of tube extrusion, the … The time course of these QOL, behavioral, and language outcomes is not specified. … The time horizons for QoL vary by key question and by study.
  18. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - changes, the list of topics designated as having potentially high impact is expected to change over time … system as of October 29, 2013, and two of them were eligible for high-impact consideration at this time … , which previously had high-impact potential, was deemed to have no high-impact potential at this time … Buprenorphine implant (Probuphine) for treatment of opioid dependence No high-impact potential at this time … new trials are needed, resubmission of a new drug application could be delayed for a considerable time
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - Long term effects of hormone therapy (HT) also were appropriately identified and reviewed, including … strongly DISAGREE with your statement that “The most important previous gaps in the evidence concerning long-termeffects of hormone therapy have been filled.” … adverse events of nonhormone therapies” Table 3 header now reads: “Inclusion/exclusion criteria for longterm effects (coronary heart disease, stroke, or venous thromboembolism; gall bladder disease; osteoporotic
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
    April 22, 2013 - Most of the time, I think, you meant "inactive control", sometimes, however, I was not sure. … At the same time, there are potential benchmarks for clinically meaningful reductions in weight (e.g … If lipid screening tests are done and lipid levels are currently normal, at what time points should … In addition, in looking at the later tables and discussion, I had a hard time figuring out what the … Unfortunately as it was received after the reviewer response deadline, the time constraints of the

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: